Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better

“In a fairly-functioning, balanced patent system…you do it once, do it right, and don’t do it again.” – Andrei Iancu

PTAB Masters

From left: Jim Carmichael, Andrei Iancu and Scott McKeown

Speakers at IPWatchdog’s PTAB Masters 2024 program this week predicted there will be little movement on the U.S. Patent and Trademark Office’s (USPTO) Advance Notice of Proposed Rulemaking anytime soon, but some pinned their hopes for change at the Patent Trial and Appeal Board (PTAB) to the pending Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.

Both panelists who typically represent petitioners and those who represent patent owners at the PTAB also agreed there are a number of ways the perception of the Board could be improved. These could include changes like allowing oral argument more often, allowing experts to testify in person, and a more meaningful rehearing procedure, for example. There was more disagreement, however, around proposals like changing the standard for patent invalidity at the PTAB to “clear and convincing” rather than “preponderance of” the evidence, and requiring that claims be interpreted using the “plain and ordinary meaning” standard used in district courts—both proposals that are in the current version of the PREVAIL Act.

Problems and Solutions

Former USPTO Director and Sullivan & Cromwell Partner, Andrei Iancu (pictured above), speaking on the first panel of the program, said the system has become too unbalanced against patent owners. Between the practice of filing serial inter partes review (IPR) petitions by the same petitioners against the same patents; parallel IPRs; multiple attacks in the district courts and at the PTAB; and the option to file a reexamination after losing an IPR, there is never quiet title for patent owners anymore, Iancu said. “In a fairly-functioning, balanced patent system…you do it once, do it right and don’t do it again,” he explained. “If a mistake is made, that’s what the appellate process is for. Not these other parallel, serial, multiple challenges in different venues.”

Jim Carmichael (pictured above) of Carmichael IP—a Diamond sponsor and co-chair of the PTAB Masters program—agreed with Iancu that there are simply too many chances to attack patents in the current system. There’s not only a second window, but a third and fourth and fifth and sixth window to challenge a particular patent, Carmichael said, adding: “Our patent owner clients would like to have their rights settled at some point.”

The PREVAIL Act would also tackle these issues, with proposals that would require standing for PTAB challengers; limit multiple petitions against the same patent by “prohibiting any entity financially contributing to a PTAB challenge from bringing its own challenge”; apply estoppel at the time the challenge is filed rather than after the Final Written Decision; and that would end the practice of filing reexaminations following failed PTAB petitions.

While the USPTO’s April 2023 ANPRM also addressed many of the issues raised by panelists during the program, sources have told IPWatchdog the latest iteration of the proposed  rules package—the Notice of Proposed Rulemaking, or NPRM, which will contain the official USPTO proposals—is currently sitting at the Office of Management and Budget (OMB) and is unlikely to move forward anytime soon as it is an election year. Furthermore, many commented that the USPTO’s proposals are likely to focus more on codifying existing USPTO precedent, such as discretionary denial practice, than on introducing any new or controversial rules.

PREVAIL and Other Prospects

From left: Tim Fink, Judge Paul Michel and Stephen McBride (Carmichael IP)

Judge Paul Michel (pictured left), who participated on a panel that reviewed pending PTAB legislation and rules on Monday, said the PREVAIL Act has a real chance because it has bipartisan support, including from the second-highest ranking Senator for the Democratic Caucus, Dick Durbin (D-IL), and because stakeholders on both sides of the issues agree there are changes that need to be made at the PTAB. For instance, Scott McKeown (pictured above) of Wolf Greenfield–also a Diamond Sponsor and co-chair of this week’s program, who represents mostly PTAB petitioners, said that allowing oral hearing more easily might help the reputation of the PTAB. The practice of requiring both parties to agree to oral hearing results in a perception that the petitioner can prevent the patent owner from being in the same room as the judges, McKeown said. “I don’t think that changes the outcome [often], but the perception is the problem,” McKeown added, explaining that such a policy simply plays into the hands of those who say the PTAB is anti-patent.

In a later panel, however, McKeown disagreed that the PREVAIL Act has a good chance of passing. “I’m not very optimistic,” McKeown commented, adding that it certainly won’t move this year and most likely not next year either. “I don’t think it’s reasonable because it’s trying to do way too much,” he added.

Let’s See the Experts

Other panelists throughout the program said experts should be testifying in front of PTAB judges more regularly, rather than just on paper. Michel said experts are often key to decision-making, citing his experience in arbitration. “Congress wanted a documentary proceeding, but what evolved is a litigation-type process with experts on both sides, and adjudicators never see them,” Michel commented. “In every arbitration case, the lightbulb went off for the arbitrators in the final round, when the experts came to the stand. That’s when it became really clear.”

Tim Fink (pictured above) of program sponsor O’Melveny & Myers, a former Vice Chief PTAB judge who was speaking on the same panel as Michel, said he thinks a lot of PTAB judges would be ok with live expert testimony but that it would have to be affordable for the PTAB and the parties.

We Need a Better PTAB Rehearing Process

From left: Raghav Bajaj (Haynes Boone); Heath Briggs (Greenberg Traurig); Meredith Addy and Lori Gordon

Another idea that seemed to garner support from both petitioner and patent owner representatives was the prospect of a rehearing process at the PTAB that actually works. Presently, parties can request rehearing, but they rarely do. According to a 2019 analysis of rehearing statistics by Foley & Lardner, more than 90% of requests for rehearing were denied.

Lori Gordon (pictured right) of Perkins Coie, who represents petitioners, said a more meaningful review process might help with the backlog of PTAB cases at the U.S. Court of Appeals for the Federal Circuit (CAFC). “Perhaps if there was a more meaningful request for rehearing process at the PTAB there would be fewer appeals to the CAFC,” Gordon said. “The success rate in rehearing is extremely low and [the Director Review process] is so narrow. If there was a meaningful process at the Board maybe that would cut down on the cases parties feel they need to appeal.”

What the CAFC Can Do

Meredith Addy (pictured above right) of AddyHart P.C. said the CAFC’s approach to reviewing PTAB cases has become a major problem for patent owners. With so many appeals from the PTAB to deal with, the CAFC has decided primarily to review cases for substantial evidence, rather than addressing legal questions. “I don’t think that’s what the CAFC is for,” Addy said. “They’re there to decide doctrines…. What if the substantial evidence the PTAB relied on was wrong?”

To illustrate her point, Addy pointed to Judge Pauline Newman’s dissent in the March 2023 precedential case of Roku v. Universal Electronics, where Newman disagreed with her colleagues’ decision to decline review of the legal questions of claim construction and obviousness de novo, and instead to review only the Board’s fact-finding. While the dissent was atypical for Newman in the sense that she was disagreeing with a decision that upheld a patent, it demonstrated her commitment to reviewing questions of law. Newman said in her dissent:

“I do not ‘assert[] that we should apply de novo review to [the factual] issue. I do assert that we should apply de novo review to the issue on appeal, that is, the legal issue of obviousness. ‘It is emphatically the province and duty of the judicial department to say what the law is. Those who apply the rule to particular cases, must of necessity expound and interpret that rule.’ Marbury v. Madison, 5 U.S. 137, 177 (1803). This foundation of appellate review applies whether or not any facts are disputed.”

Judge Michel said the CAFC can also help by clarifying issues like claim construction and written description. “[Claim construction law] is a mess,” Michel said. “That’s [the CAFC’s] fault. They have numerous inconsistent decisions on claim construction. They need to go en banc and clarify that.”

Michel also said examiners too often issue broad claims because they aren’t applying Section 112 correctly, which results in easily invalidated patents, and that the CAFC can do more to curb that. “The applicant should get what they’re entitled to and not what they’re not entitled to,” Michel said.

Be Ethical—and Reasonable

Judge Michael Tierney

Other panels throughout the program tackled the ways that litigation finance factors into PTAB strategies, off-the-record discussions featuring stakeholder and judges’ perspectives on PTAB practice, ethics issues at the PTAB, and more.

During the ethics session on day two, PTAB Vice Chief Judge Michael Tierney said parties need to be especially careful about making inconsistent statements between the PTAB and district courts and also should avoid pushing too hard to penalize their opponents when they make very minor mistakes. While the practitioners on the panel expressed frustration about the other side sometimes not following the rules, such as missing deadlines, Tierney said the Board notices repeat infractions and that “they do have a cumulative effect,” but to be wary of being petty.

“I don’t mind someone pointing out a minor infraction, but don’t ask for fire and brimstone,” Tierney said. “If there’s something egregious, bring it to our attention and ask for sanctions,” he added, but urged attendees to be able to explicitly explain what the prejudice is if they’re pushing back on something minor.

Check out IPWatchdog’s calendar to join us for our next live program.

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.

Join the Discussion

15 comments so far. Add my comment.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    February 7, 2024 12:44 pm

    F22, I would agree with almost everything you said except for “the number of different companies the patent owner has sued or threatened to sue on the same patent … is directly proportional to the commercial value of its claimed invention. There have been ample examples of patents some PAEs have sued plural companies on that turned out not to be infringed by any of them, i.e., not commercially used at all. Also, re Anon’s comment, lets not confuse the AIA statutory burden on patent owners to separately sue separate defendants with the refusals of different defense counsels to cooperate on joint defense actions, which was occurring, or not, long before that statute. Also, even when several defendants Could be sued in one lawsuit, that did NOT preclude their entitlement to separate PTO reexaminations and other separate defenses.
    As to this blog’s suggestion of changing the statute to raise the burden of proof in an IPR to “clear and convincing evidence” rather than a preponderance: That is a reasonable suggestion, which, if was not part of a statutory proposal full of other controversial issues, might even have a chance of enactment. However, the impact is not likely to be significant, since IPR decisions can only be based on the contents of patents and publications, not unsupported oral testimony.

  • [Avatar for Anon]
    Anon
    February 4, 2024 10:03 am

    Mr. Morgan continues his one-sided cheerleading of IPRs – oblivious to their being an attack on a strong patent system.

    Below he admonishes “lack of concerted effort,” but has remained ever silent when he has (repeatedly) been reminded that the AIA made it necessary to proliferate law suits by NOT ALLOWING non-practicing entities to consolidate their efforts.

    No answer from him on this point of hypocrisy == ownership of that hypocrisy.

  • [Avatar for F22strike]
    F22strike
    February 3, 2024 01:47 pm

    Paul –

    You said “Actually, it is proportional to the number of different companies the patent owner has sued or threatened to sue on the same patent . . ” which in turn indicates that the number of serial (and parallel) IPRs that a US patent will encounter is directly proportional to the commercial value of its claimed invention. Multiple patent infringement lawsuits on the same patent against different defendants occur where an invention has demonstrated overwhelming commercial success yet the relevant industry refuses to license the patents covering the patented invention.

    Caltech’s WiFi patents have extremely high commercial value. You are probably using these inventions right now if you are using WiFi. Thus these patents have been the subject of multiple infringement lawsuits filed against big-tech companies who have refused to license the same patents. These lawsuits have in turn resulted in eighteen (18) IPRs.

    Sure, unless and until the claims of a US patent are invalidated in a final judgment, subject to exceptions based on privity and collateral estoppel, each defendant gets the opportunity to put on a defense when charged with infringement of those claims. However, as a practical matter, at some point the most pertinent prior art has already been considered in IPRs against those patent claims. Yet the USPTO seems more than willing to continue to grant new IPR petitions. IMO, it has a perverse financial incentive to do so and it is no longer seeking to “get rid of bad patents”. IMO, it is doing big-tech’s bidding in return for massive USPTO fees and bonuses paid to PTAB administrative law judges. IMO, the deciders in the IPR machine have massive conflicts of interest.

    And what is wrong with Caltech, as you put it ” demanding large amounts of money from each”? Caltech can only recover reasonable royalty damages in a patent infringement lawsuit since it does not manufacture any patented products and therefore has no lost profits. Are you against colleges and universities licensing their patented inventions so they can continue to fund groundbreaking research and provide financial assistance to their students? Do you accept big-tech’s efficient infringer model which is based on paying huge legal fees in lieu of patent royalties?

    Any reasonable person would have to admit that the current US patent system is completely rigged against innovators and in favor of big-tech, in the federal courts, at the USPTO, and in Congress.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    February 2, 2024 06:55 pm

    Re the above assertion that “The number of serial IPRs that a US patent will encounter is directly proportional to the commercial value of its claimed invention.”
    Actually, it is proportional to the number of different companies the patent owner has sued or threatened to sue on the same patent, demanding large amounts of money from each. As the very example of multiple IPRs you cite demonstrates. The PTO has actual published statistics on how very rarely plural IPRs against the same patent happens. Each threatened independent company is legally entitled to its own defense in its own case in court and in an IPR. The all to frequent failure of their law firms to cooperatively engage in joint defense agreements is not the fault of the IPR system. Nor are the courts, the PTAB or the parties helpless in such situations to avoid duplicate efforts, with consolidations, joinders, etc.

  • [Avatar for F22strike]
    F22strike
    February 2, 2024 03:38 pm

    Paul –

    The number of serial IPRs that a US patent will encounter is directly proportional to the commercial value of its claimed invention.

    The last time I checked, Caltech’s WiFi patents have faced eighteen (18) serial IPR petitions. The infringed claims have survived to date, but Microsoft, HP, Dell, etc. still refuse to enter into license agreements with respect to these patents.

    Clearly, a US patent that does not claim an invention with demonstrated commercial success will likely never be involved in an IPR proceeding.

    The question remains. Why would any rational decision maker invest tens of thousands of dollars in trying to obtain a US patent? If the invention turns out to be a commercial success (the odds are against this), competitors will copy the invention. If the patent owners sues to enforce the patent, the litigation will be stayed in favor of a subsequently filed IPR petition. Then there is an 80-90% chance that the patent will have its challenged claims cancelled as a result of one or more IPR proceedings. On top of that, the patent owner gets to waste another $250-500K in attorneys fees in trying to defend that patent in each IPR proceeding.

  • [Avatar for Sarah Mcpherson]
    Sarah Mcpherson
    February 2, 2024 07:08 am

    How can the USPTO award IP,and then are allowed protection when challenged? Why dies the USPTO take money from inventors knowing they are just stealing from them? I’m pretty sure that defines fraud.

  • [Avatar for Josh Malone]
    Josh Malone
    February 1, 2024 11:31 pm

    PTAB serves no legitimate purpose. It is fundamentally flawed. You can’t give the USPTO a mulligan on every patent. You can’t have bureaucrats revoking property rights. It cannot be reformed. It’s a failure. It’s existence is antithetical to promoting progress in the useful arts and securing to inventors the exclusive right to their discoveries.

    But these proposed reforms will ensure it remains effective at destroying small businesses and creating multi-trillion dollar monopolies.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    February 1, 2024 07:26 pm

    The comment above makes a valid point that neither inventors or their owner-clients are adequately warned before patent filing decisions of the existence of reexaminations and IPRs based on very much better prior art searches that they may well encounter IF they SUE on their patents. More seriously, even some clients actively considering filing lawsuits do not seem to have been adequately so counseled, and fail to do their own thorough prior art searches or any consideration of reexamination claim improvements before suing.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    February 1, 2024 07:14 pm

    Reexaminations of the same claims after an IPR petition refusal or IPR favorable decision is not common, but the PTO should be carefully restricting them, as suggested. Serial or parallel IPRs are not that common either, and being reduced.
    As for “changes like allowing oral argument more often, allowing experts to testify in person, and a more meaningful rehearing procedure,” there a few cases where such a request is appropriate, but I doubt if these would change many results. Cross-examination is oral. But it would likely be used for delaying purposes. Nor is extensive reconsideration of a final decision, vis a vis appeal, typical in other administrative or judicial proceedings. Likewise, reexamination reversals are uncommon. They are for clear errors, clearly pointed out, not re-arguments.

  • [Avatar for F22strike]
    F22strike
    February 1, 2024 05:52 pm

    “37 CFR § 11.701 Communications concerning a practitioner’s services.
    A practitioner shall not make a false or misleading communication about the practitioner or the practitioner’s services. A communication is false or misleading if it contains a material misrepresentation of fact or law, or omits a fact necessary to make the statement considered as a whole not materially misleading.”

    Assume that a patent attorney failed to inform his or her client that any US patent they might obtain for the client will likely be unenforceable based on claim cancellation statistics in IPR proceedings. Assume further that the client spent $50K in attorney fees and costs obtaining a US patent and another $450K in attorney fees and costs in IPR proceedings, only to have all claims of the patent cancelled.

    There are plenty of plaintiff’s attorneys that would love to try a malpractice case against that patent attorney before a jury based on this scenario. The disgruntled patent owner would surely testify that he/she thought that the patent would give him/her exclusive rights to the invention and that he/she was never informed that it was so easy for the US government to take his/her patent away. The plaintiff’s attorney would argue for an award of damages in the amount of $500K plus lost profits (due to copy-cat competitors) in an amount based on the testimony of a damages expert. Even if the patent attorney wins the malpractice case, that attorney will still suffer a great deal in lost time, lost billing, and emotional distress.

  • [Avatar for Anon]
    Anon
    February 1, 2024 03:15 pm

    Pardon a quick comment (have not read existing comments yet) – but the headline screams to me of the concept of incontestability.

    I wonder though – would a direct path be more forthcoming if we took the Supreme Court at its word (for their no-doubt, unintended consequence) and looked at the personal property right of a “Public Franchise” and attached typical duties of a FranchisOR to a FranchisEE?

    Duties such as defense of the item?

    Reimbursement of any lost expectation revenue?

    I mean, it MUST mean something for a FranchisOR to take money and grant the item that the FranchisEE is granted, right?

  • [Avatar for Alan]
    Alan
    January 31, 2024 08:28 pm

    F22Strike nailed it for the most part. You can further add many APJs are not skilled in the relevant art and they cannot tell when a so-called “expert” is full of crap. Expert declarations are drafted by counsel with varying levels of input from alleged experts. In a recent case the expert input was substantially nil. At least this came out in a deposition, but oftentimes that sort of information will not be revealed (noting that in recent years patent owner counsel is more likely to press this issue during a deposition). So you have the battle of the experts on paper with no live testimony or cross-examination and if a PTAB panel has a bias toward finding claims invalid (and yes, some panels have taken the position that a patent owner has to prove patentability even though the rules and CAFC have determined otherwise) it is very likely such panels will find a way to invalidate the claims.
    This needs congressional action to fix, beginning with no joinder of parties that would otherwise be barred for having an IPR instituted and also requiring standing.

  • [Avatar for Pro Say]
    Pro Say
    January 31, 2024 03:03 pm

    What both F22strike and Patent Owner said.

    Only a return to America’s patent past will protect America’s innovation of the future.

    Our past holds the key to our future.

    Use that key Congress. Use. That. Key.

  • [Avatar for F22strike]
    F22strike
    January 31, 2024 02:15 pm

    The death knell sounded for the US Patent system with the passage of the AIA in 2012 at the behest of big-tech and its lobbyists. To summarize, it implemented IPR proceedings resulting in:

    1) US District Courts almost always staying patent infringement lawsuits in deference to the USPTO, thus effectively denying the patent owner of the presumption of validity, the clear and convincing burden for proving invalidity, and the Seventh Amendment right to a jury trial;

    2) no presumption of validity during IPR proceedings;

    3) broadest reasonable interpretation (BRI) of claim terms during IPR proceedings;

    4) unlimited serial IPRs;

    5) no standing requirement for filing an IPR petition;

    6) huge financial incentives for the USPTO and the administrative law judges on the PTAB to receive and grant IPR petitions;

    7) stacking panels at the PTAB to make sure that challenges are successful in selected high profile IPRs; and

    8) 80-90% cancellation of patent claims as a result of IPR proceedings.

    Adding insult to injury, there is a growing trend of challengers instituting re-examination proceedings when IPR petitions are denied.

    Big-tech is successfully using its lobbyists to ensure that there will be no meaningful patent reform by Congress. The US public couldn’t care less about the US patent system and therefore the members of the House and Senate have no incentive to fix the problem. If you disagree, please post a link to a video showing protestors waving signs saying “REFORM PATENT LAW NOW!”

    IPR proceedings and a string of anti-patent decisions from the SCOTUS commencing with the 2006 eBay case, have made nearly all US patents worthless. Except in rare cases, they cannot be enforced. IMO, patent attorneys have an ethical responsibility to explain this to their clients prior to preparation and filing of any US patent applications. Failure to do so raises the ugly specter of having to defend a malpractice lawsuit for failure to obtain informed consent.

  • [Avatar for Patent Owner]
    Patent Owner
    January 31, 2024 08:54 am

    Same ole conversations.

    When is someone going to actually do something ?

    When?

Add Comment

Your email address will not be published. Required fields are marked *